Literature DB >> 17643544

Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.

Stephanie E A Gratton1, Patrick D Pohlhaus, Jin Lee, Ji Guo, Moo J Cho, Joseph M Desimone.   

Abstract

A novel method for the fabrication of polymeric particles on the order of tens of nanometers to several microns is described. This imprint lithographic technique called PRINT (Particle Replication In Non-wetting Templates), takes advantage of the unique properties of elastomeric molds comprised of a low surface energy perfluoropolyether network, allowing the production of monodisperse, shape-specific nanoparticles from an extensive array of organic precursors. This engineered nature of particle production has a number of advantages over the construction of traditional nanoparticles such as liposomes, dendrimers, and colloidal precipitates. The gentle "top down" approach of PRINT enables the simultaneous and independent control over particle size and shape, composition, and surface functionality, and permits the loading of delicate cargos such as small organic therapeutics and biological macromolecules. Thus, this single tool serves as a comprehensive platform for the rational design and investigation of new nanocarriers in medicine, having applications ranging from therapeutics to advanced diagnostics. Preliminary in vitro and in vivo studies were conducted, demonstrating the future utility of PRINT particles as delivery vectors in nanomedicine. Monodisperse 200 nm poly(ethylene glycol)-based (PEG) particles were fabricated using PRINT methodology and characterized via scanning electron microscopy and dynamic light scattering. Incubation with HeLa cells showed very little cytotoxicity, even at high concentrations. The biodistribution and pharmacokinetics of [(125)I]-labeled particles were studied in healthy mice following bolus tail vein administration. The particles were distributed mainly to the liver and the spleen with an apparent distribution t(1/2) of approximately 17 min followed by slow redistribution with a t(1/2) of 3.3 h. The volume of distribution for the central and peripheral compartments was found to be approximately 3 mL and 5 mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643544      PMCID: PMC1994820          DOI: 10.1016/j.jconrel.2007.05.027

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

Review 1.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Authors:  D C Drummond; O Meyer; K Hong; D B Kirpotin; D Papahadjopoulos
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-06-08       Impact factor: 15.470

3.  Controlling liposome blood clearance by surface-grafted polymers.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-06-08       Impact factor: 15.470

4.  High-resolution soft lithography: enabling materials for nanotechnologies.

Authors:  Jason P Rolland; Erik C Hagberg; Ginger M Denison; Kenneth R Carter; Joseph M De Simone
Journal:  Angew Chem Int Ed Engl       Date:  2004-11-05       Impact factor: 15.336

5.  Acid-triggered transformation of diortho ester phosphocholine liposome.

Authors:  Zhaohua Huang; Xin Guo; Weijun Li; J Andrew MacKay; Francis C Szoka
Journal:  J Am Chem Soc       Date:  2006-01-11       Impact factor: 15.419

Review 6.  Imparting size, shape, and composition control of materials for nanomedicine.

Authors:  Larken E Euliss; Julie A DuPont; Stephanie Gratton; Joseph DeSimone
Journal:  Chem Soc Rev       Date:  2006-09-20       Impact factor: 54.564

Review 7.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

8.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.

Authors:  K Kataoka; T Matsumoto; M Yokoyama; T Okano; Y Sakurai; S Fukushima; K Okamoto; G S Kwon
Journal:  J Control Release       Date:  2000-02-14       Impact factor: 9.776

Review 9.  Engineering liposomes for drug delivery: progress and problems.

Authors:  G Gregoriadis
Journal:  Trends Biotechnol       Date:  1995-12       Impact factor: 19.536

10.  The effect of aging on the physical stability of liposome dispersions.

Authors:  M Grit; D J Crommelin
Journal:  Chem Phys Lipids       Date:  1992-09       Impact factor: 3.329

View more
  66 in total

Review 1.  Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Authors:  William C Zamboni; Vladimir Torchilin; Anil K Patri; Jeff Hrkach; Stephen Stern; Robert Lee; Andre Nel; Nicholas J Panaro; Piotr Grodzinski
Journal:  Clin Cancer Res       Date:  2012-06-05       Impact factor: 12.531

2.  Hydrogel microparticles from lithographic processes: novel materials for fundamental and applied colloid science.

Authors:  Matthew E Helgeson; Stephen C Chapin; Patrick S Doyle
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-04-01       Impact factor: 6.448

3.  Precise control of PLG microsphere size provides enhanced control of drug release rate.

Authors:  Cory Berkland; Martin King; Amanda Cox; Kyekyoon Kim; Daniel W Pack
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

4.  Spatiotemporal control over molecular delivery and cellular encapsulation from electropolymerized micro- and nanopatterned surfaces.

Authors:  Eric Stern; Steven M Jay; Stacey L Demento; Ryan P Murelli; Mark A Reed; Tadeusz Malinski; David A Spiegel; David J Mooney; Tarek M Fahmy
Journal:  Adv Funct Mater       Date:  2009-07-13       Impact factor: 18.808

Review 5.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 6.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

7.  Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Authors:  Dawei Ding; Xiaolei Tang; Xiaoli Cao; Jinhui Wu; Ahu Yuan; Qian Qiao; Jing Pan; Yiqiao Hu
Journal:  AAPS PharmSciTech       Date:  2013-11-28       Impact factor: 3.246

8.  Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.

Authors:  Anthony D Duong; Sadhana Sharma; Kevin J Peine; Gaurav Gupta; Abhay R Satoskar; Eric M Bachelder; Barbra E Wyslouzil; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

9.  Scalable, shape-specific, top-down fabrication methods for the synthesis of engineered colloidal particles.

Authors:  Timothy J Merkel; Kevin P Herlihy; Janine Nunes; Ryan M Orgel; Jason P Rolland; Joseph M DeSimone
Journal:  Langmuir       Date:  2010-08-17       Impact factor: 3.882

10.  Nanogel Carrier Design for Targeted Drug Delivery.

Authors:  D M Eckmann; R J Composto; A Tsourkas; V R Muzykantov
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.